5V7Z

SSNMR Structure of the Human RIP1/RIP3 Necrosome


SOLID-STATE NMR
NMR Experiment
ExperimentTypeSample ContentsSolventIonic StrengthpHPressureTemperature (K)Spectrometer
1DARR 250 MS15 mg/mL [U-100% 13C; U-100% 15N] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE II 900
2DARR 250 MS15 mg/mL [U-100% 15N; 2-13C-GLYCEROL] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE II 900
3DARR 250 MS15 mg/mL [U-100% 15N; 1,3-13C-GLYCEROL] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE II 900
4CHHC 500 US15 mg/mL [U-100% 13C; U-100% 15N] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE 750
5CHHC 500 US15 mg/mL [U-100% 15N; 1,3-13C-GLYCEROL] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE 750
6PAR 15 MS15 mg/mL [U-100% 15N; 2-13C-GLYCEROL] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE 750
7PAR 15 MS15 mg/mL [U-100% 15N; 1,3-13C-GLYCEROL] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE 750
8PAIN 6 MS15 mg/mL [U-100% 15N; 2-13C-GLYCEROL] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE 750
9PAIN 6 MS15 mg/mL [U-100% 15N; 1,3-13C-GLYCEROL] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE 750
10TEDOR 8 MS15 mg/mL [U-100% 13C; U-100% 15N] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE 750
11TEDOR 8 MS15 mg/mL [U-100% 15N; 2-13C-GLYCEROL] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE 750
12TEDOR 8 MS15 mg/mL [U-100% 15N; 1,3-13C-GLYCEROL] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE 750
13NCOCX15 mg/mL [U-100% 13C; U-100% 15N] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE 750
14NCOCA15 mg/mL [U-100% 13C; U-100% 15N] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE 750
15NCACX15 mg/mL [U-100% 13C; U-100% 15N] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE 750
16NCA15 mg/mL [U-100% 13C; U-100% 15N] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE 750
17DARR 50 MS15 mg/mL [U-100% 13C; U-100% 15N] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE II 900
18DARR 50 MS15 mg/mL [U-100% 15N; 2-13C-GLYCEROL] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE II 900
19DARR 50 MS15 mg/mL [U-100% 15N; 1,3-13C-GLYCEROL] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE II 900
20DARR 20 MS15 mg/mL [U-100% 13C; U-100% 15N] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE II 900
21DARR 20 MS15 mg/mL [U-100% 15N; 2-13C-GLYCEROL] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE II 900
22DARR 20 MS15 mg/mL [U-100% 15N; 1,3-13C-GLYCEROL] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE II 900
23DARR 100 MS15 mg/mL [U-100% 13C; U-100% 15N] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE II 900
24DARR 100 MS15 mg/mL [U-100% 15N; 2-13C-GLYCEROL] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE II 900
25DARR 100 MS15 mg/mL [U-100% 15N; 1,3-13C-GLYCEROL] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE II 900
26DARR 500 MS15 mg/mL [U-100% 13C; U-100% 15N] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE II 900
27DARR 500 MS15 mg/mL [U-100% 15N; 2-13C-GLYCEROL] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE II 900
28DARR 500 MS15 mg/mL [U-100% 15N; 1,3-13C-GLYCEROL] RIP1/RIP3100% H2O06.51 atm278Bruker AVANCE II 900
NMR Spectrometer Information
SpectrometerManufacturerModelField Strength
1BrukerAVANCE II900
2BrukerAVANCE750
NMR Refinement
MethodDetailsSoftware
torsion angle dynamicsCYANA
molecular dynamicsAmber
NMR Ensemble Information
Conformer Selection Criteriastructures with the lowest energy
Conformers Calculated Total Number100
Conformers Submitted Total Number10
Representative Model1 (target function)
Computation: NMR Software
#ClassificationVersionSoftware NameAuthor
1structure calculationCYANA3.97Guntert, Mumenthaler and Wuthrich
2refinementAmberCase, Darden, Cheatham III, Simmerling, Wang, Duke, Luo, ... and Kollman
3chemical shift assignmentSparkyGoddard
4peak pickingSparkyGoddard